Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NOVN Novartis	CHF90.54	1.7%	-1.5%	CHF184.7b	CHF98.47	PE22.3x	E9.9%	3.6%
ROG Roche Holding	CHF222.30	0.8%	-20.7%	CHF179.4b	CHF279.39	PE15.4x	E8.6%	4.3%
LONN Lonza Group	CHF526.40	3.1%	-7.0%	CHF38.0b	CHF573.86	PE58x	E19.9%	0.8%
GALD Galderma Group	CHF71.09	3.8%	n/a	CHF16.9b	CHF76.55	n/a	n/a	n/a
SDZ Sandoz Group	CHF31.50	1.1%	n/a	CHF13.5b	CHF35.01	PE193.6x	E29.8%	1.4%
BANB Bachem Holding	CHF81.25	1.4%	-12.6%	CHF6.1b	CHF70.80	PE54.5x	E15.4%	1.0%
TECN Tecan Group	CHF331.60	1.4%	-11.7%	CHF4.2b	CHF395.57	PE32.2x	E9.2%	0.9%
SFZN Siegfried Holding	CHF859.00	-2.6%	18.7%	CHF3.7b	CHF1,015.90	PE32.7x	E14.7%	0.4%
DESN Dottikon ES Holding	CHF253.50	5.6%	11.9%	CHF3.5b	n/a	PE40.5x	n/a	0%
SKAN SKAN Group	CHF81.40	-0.5%	0.5%	CHF1.8b	CHF91.33	PE69.6x	E34.8%	0.4%
COPN Cosmo Pharmaceuticals	CHF71.00	-1.8%	35.8%	CHF1.1b	CHF93.31	PE1018.5x	E30.4%	2.7%
PPGN PolyPeptide Group	CHF30.85	1.8%	27.4%	CHF1.0b	CHF24.55	PS3.3x	E0.07%	0%
BSLN Basilea Pharmaceutica	CHF42.85	8.2%	-6.4%	CHF517.3m	CHF70.58	PE49.5x	E32.4%	0%
IDIA Idorsia	CHF2.11	16.5%	-74.1%	CHF377.3m	CHF1.72	PS2x	E22.2%	n/a
KURN Kuros Biosciences	CHF6.60	1.9%	368.1%	CHF243.6m	n/a	PS7.3x	n/a	n/a
XLS Xlife Sciences	CHF35.30	10.3%	0.9%	CHF201.3m	CHF68.00	PE13.5x	n/a	n/a
NWRN Newron Pharmaceuticals	CHF9.81	19.5%	115.1%	CHF182.8m	CHF14.56	PS20.7x	E56.8%	n/a
MOLN Molecular Partners	CHF3.25	-1.2%	-45.8%	CHF107.8m	CHF9.35	PS15.3x	E5.1%	n/a
SANN Santhera Pharmaceuticals Holding	CHF9.29	0.3%	50.1%	CHF105.2m	CHF30.00	PE1.9x	n/a	n/a
CURN Curatis Holding	CHF8.43	-48.1%	n/a	CHF37.0m	n/a	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF1.22	-1.6%	-82.6%	CHF15.3m	n/a	PS2.4x	n/a	n/a
ADXN Addex Therapeutics	CHF0.073	20.3%	-44.0%	CHF9.4m	n/a	PS5.7x	E119.0%	n/a
SPEX Spexis	CHF0.063	7.1%	-82.0%	CHF4.3m	n/a	PS3.6x	n/a	n/a
KNRS Kinarus Therapeutics Holding	CHF16.13	5.9%	-66.7%	CHF3.9m	n/a	n/a	n/a	n/a